20/20 Biolabs Statistics
NASDAQ: AIDXHealth CarePrecision InstrumentsUSD
0.1571-0.0245 (-13.49%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
20/20 Biolabs by the numbers
20/20 Biolabs has a market capitalization of $2.2 million based on 13.99M shares outstanding. With trailing EPS of $-0.75, 20/20 Biolabs is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 49.4% below its 50-day average and 87.6% below its 200-day average.
Average daily trading volume is 139.24K shares, or about $21,875 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
Valuation
- Market cap
- $2.20M
- Price / sales (latest FY)
- 1.07
- EPS (TTM)
- $-0.75
- Shares outstanding
- 13.99M
Price and trading
- Previous close
- 0.1816
- Open
- 0.1802
- Day range
- 0.1556 – 0.1803
- 52-week range
- 0.1556 – 50.00
- 50-day moving average
- 0.3104
- Beta
- —
- Volume
- 301.48K
- Average volume
- 139.24K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 2.20M
- Eps
- -0.75
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 50.00
- Week52 Low
- 0.16
- Avg Volume
- 139.24K
- Shares Outstanding
- 13.99M
- Ma50
- 0.31
- Ma200
- 1.27
- Pct From52w High
- -99.69%
- Pct From52w Low
- 0.96%